You are here

Clinical Trials: Lung Disease



Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, August 24, 2018 - 12:00
Condition:   Bronchopulmonary Dysplasia
Interventions:   Drug: Human Umbilical Cord-derived Mesenchymal stem cell;   Drug: placebo
Sponsor:   Children's Hospital of Fudan University
Not yet recruiting
Posted: Wednesday, August 15, 2018 - 12:00
Condition:   Bronchopulmonary Dysplasia
Intervention:   Biological: Human Umbilical Cord Derived-Mesenchymal Stem Cells
Sponsor:   Meridigen Biotech Co., Ltd.
Not yet recruiting
Posted: Thursday, July 26, 2018 - 12:00
Condition:   Refractory Pulmonary Diseases
Interventions:   Drug: Transplantation of mesenchymal stem cell;   Drug: No Transplantation of Mesenchymal Stem Cell
Sponsor:   Children's Hospital of Chongqing Medical University
Posted: Friday, June 15, 2018 - 12:00
Condition:   Bronchopulmonary Dysplasia
Interventions:   Drug: Transplantation of mesenchymal stem cell;   Drug: No transplantation of mesenchymal stem cell
Sponsor:   Children's Hospital of Chongqing Medical University
Posted: Tuesday, June 12, 2018 - 12:00
Conditions:   Acute Respiratory Distress Syndrome (ARDS);   Multiple Organ Failure
Intervention:   Biological: MSC
Sponsor:   Fujian Medical University
Not yet recruiting
Posted: Friday, June 8, 2018 - 12:00
Condition:   Pulmonary Arterial Hypertension
Intervention:   Behavioral: Endurance training
Sponsor:   Hospital Clinic of Barcelona
Posted: Monday, January 8, 2018 - 12:00
Condition:   Severe Bronchopulmonary Dysplasia
Interventions:   Biological: PNEUMOSTEM;   Other: Placebo
Sponsor:   Medipost Co Ltd.
Not yet recruiting
Posted: Tuesday, December 19, 2017 - 12:00
Condition:   Bronchopulmonary Dysplasia
Interventions:   Drug: transplantation of mesenchymal stem cell;   Drug: no transplantation of mesenchymal stem cell
Sponsors:   Daping Hospital and the Research Institute of Surgery of the Third Military Medical University;   Children's Hospital of Chongqing Medical University;   Chongqing Maternal and Child Health Hospital
Posted: Tuesday, May 9, 2017 - 12:00
Condition:   Bacterial Pneumonia
Intervention:   Drug: Cx611 or Placebo
Sponsors:   TiGenix S.A.U.;   European Commission;   Centre Hospital Regional Universitaire de Limoges;   Cliniques universitaires Saint-Luc- Université Catholique de Louvain;   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);   Hospital San Carlos, Madrid
Recruiting - verified May 2017
Posted: Tuesday, May 2, 2017 - 12:00
Condition:   Pulmonary Arterial Hypertension (PAH)
Interventions:   Biological: Allogeneic Human Cardiosphere-Derived Stem Cells;   Biological: Placebo
Sponsors:   Cedars-Sinai Medical Center;   California Institute for Regenerative Medicine
Not yet recruiting - verified May 2017